LENSAR, Inc. (LNSR)
NASDAQ·Healthcare·Medical - Devices
$5.39
+3.45%
Mkt Cap $142.02M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $20.28M | $12.65M | -37.63% | -$0.07 | -$0.12 | -80.72% | — | — |
| Q4 2025 Nov 6, 2025 | $20.30M | $14.32M | -29.48% | -$0.10 | -$0.31 | -210.00% | — | — |
| Q3 2025 Aug 7, 2025 | $17.75M | $13.94M | -21.49% | -$0.08 | -$0.15 | -87.50% | — | — |
| Q2 2025 May 8, 2025 | $13.40M | $14.16M | +5.66% | -$0.15 | -$2.32 | -1446.67% | — | — |
| Q1 2025 Feb 27, 2025 | $14.00M | $16.73M | +19.51% | -$0.18 | -$1.61 | -794.44% | — | — |
| Q4 2024 Nov 7, 2024 | $14.95M | $13.54M | -9.44% | -$0.29 | -$0.13 | +55.17% | — | — |
| Q3 2024 Aug 8, 2024 | $12.15M | $12.64M | +4.00% | -$0.29 | -$0.53 | -82.76% | — | — |
| Q2 2024 May 9, 2024 | $10.55M | $10.59M | +0.36% | -$0.28 | -$0.19 | +32.14% | — | — |
| Q1 2024 Mar 4, 2024 | $12.00M | $12.11M | +0.88% | -$0.22 | -$0.35 | -59.09% | — | — |
| Q4 2023 Nov 9, 2023 | $12.00M | $9.79M | -18.38% | -$0.34 | -$0.23 | +32.35% | — | — |
| Q3 2023 Aug 9, 2023 | $10.00M | $12.01M | +20.12% | -$0.35 | -$0.81 | -131.43% | — | — |
| Q2 2023 May 15, 2023 | $9.10M | $8.25M | -9.32% | -$0.27 | -$0.40 | -48.15% | — | — |
| Q1 2023 Mar 16, 2023 | $10.00M | $10.23M | +2.32% | $0.25 | -$0.24 | -196.00% | — | — |
| Q4 2022 Nov 9, 2022 | $7.90M | $7.75M | -1.92% | -$0.62 | -$0.39 | +37.10% | — | — |
| Q3 2022 Aug 8, 2022 | $9.20M | $8.04M | -12.63% | -$0.72 | -$0.67 | +6.94% | — | — |
| Q2 2022 May 9, 2022 | $8.71M | $9.34M | +7.28% | -$0.88 | -$0.67 | +23.86% | — | — |
| Q1 2022 Mar 3, 2022 | $8.68M | $11.22M | +29.27% | -$0.60 | -$0.41 | +31.67% | — | — |
| Q4 2021 Nov 8, 2021 | $7.67M | $8.27M | +7.85% | -$0.59 | -$0.65 | -10.17% | — | — |
| Q3 2021 Aug 5, 2021 | $7.92M | $7.92M | +0.00% | -$0.59 | -$0.47 | +20.34% | — | — |
| Q2 2021 May 5, 2021 | $5.28M | $7.04M | +33.33% | -$0.33 | -$0.56 | -69.70% | — | — |